Aurinia Pharmaceuticals Inc.
AUPH | NASDAQ
$16.73
+$0.12 (+0.72%)
Sep 22, 2026, 1:52 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 71.77M | 34.36M | 210.79M | 31.55M | 21.51M | 23.34M | 1.43M | 14.35M | 722K | -10.75M | -26.88M | -13.45M | -11.49M | -26.21M | -26.05M | -8.99M | -35.52M | -37.63M | -33.32M | -50.26M | -47.01M | -50.38M |
Depreciation & Amortization | 9.65M | 2.5M | 4.86M | 4.87M | 4.86M | 4.86M | 4.86M | 4.89M | 4.84M | 4.85M | 4.95M | 5.26M | 719K | 717K | 219K | 809K | 840K | 838K | 688K | 766K | 848K | 416K |
Stock-Based Compensation | 1.97M | -866K | n/a | 5.92M | 5.44M | -3.41M | 8.95M | 8.33M | 8.59M | 5.74M | 11.77M | 11.81M | 12.27M | 9.47M | 6.9M | 8.32M | 10.06M | 7.02M | 8.58M | 7.09M | 7.75M | 7.82M |
Other Working Capital | -6.2M | -3.78M | 17.22M | -6.01M | 6.68M | -13.23M | 23.13M | 2.57M | -1.9M | -7.23M | 10.88M | -5.44M | -1.38M | 3.42M | 1.42M | 944K | -5.93M | 139K | 4.12M | -4.57M | -2.24M | 1.01M |
Other Non-Cash Items | -42.42M | 165K | -1.23M | -1.85M | 6.7M | 1.48M | -7.6M | 867K | -3.45M | -7.67M | 5.04M | -3M | -6.44M | -2.39M | 283K | 540K | 997K | 1.51M | -102K | 13.91M | -793K | -2.11M |
Deferred Income Tax | 20.39M | 9.28M | -176.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -8.8M | -12.87M | 6.71M | 3.97M | 5.73M | -24.97M | 22.48M | -11.41M | 5.14M | -10.76M | 19.43M | -13.9M | 2.12M | -13.25M | 29.09M | -16.04M | -4.25M | -18.49M | -1.76M | -11.76M | 1.22M | -9.29M |
Operating Cash Flow | 52.57M | 32.56M | 44.57M | 44.45M | 44.24M | 1.3M | 30.11M | 17.03M | 15.84M | -18.6M | 14.31M | -13.28M | -2.83M | -31.67M | 10.45M | -15.36M | -27.87M | -46.75M | -25.92M | -40.25M | -37.98M | -53.54M |
Capital Expenditures | -39K | -39K | -69.76K | -65K | -98K | -17K | -56K | -85K | -128K | -12K | -59K | 105K | -227K | -509K | -134K | -37.68K | -39K | -79K | -35K | -159K | -228K | -1.18M |
Cash Acquisitions | 5.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 37.68K | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -150.81M | -127.04M | -289.24M | -107.21M | -145.43M | -91.99M | -84.69M | -143.01M | -196.87M | -121.26M | -144.29M | n/a | -114.04M | -142.4M | n/a | -170.23M | -69.45M | -163.5M | -96.13M | -125.84M | n/a | -115.17M |
Sales Maturities Of Investments | 209M | 109M | 238.85M | 93.5M | 132.25M | 123.04M | 123.97M | 132.57M | 158.37M | 170.51M | 138.09M | n/a | 120.53M | 167.77M | n/a | 120.43M | 115.11M | 110.57M | 90.68M | 99.1M | n/a | 60.94M |
Other Investing Acitivies | 18.08M | n/a | 13.71M | n/a | n/a | n/a | 226K | -269K | n/a | n/a | 240K | -19.81M | -11.91M | -162K | -2.88M | -421K | n/a | n/a | n/a | -6.16M | 1.9M | -12.88M |
Investing Cash Flow | 81.45M | -18.08M | -36.89M | -13.77M | -13.27M | 31.03M | 39.22M | -10.57M | -38.62M | 49.23M | -6.26M | -19.7M | -5.61M | 24.86M | -3.02M | -50.22M | 45.62M | -53.02M | -5.49M | -32.81M | 1.67M | -67.25M |
Debt Repayment | -7.06M | -3.65M | -3.37M | -3.45M | -3.43M | -2.77M | -3.03M | -2.96M | -3.22M | -2.78M | -6.54M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -74.88M | -36.17M | 1.3M | -9.04M | -42.56M | -46.92M | -21.8M | n/a | -6.13M | -12.3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 86.75M | -14.58M | -240.16K | 1.99M | 1.6M | 355K | 1.79M | 236K | 1.08M | 28K | 966K | -2.33M | 1.14M | 1.64M | 688K | n/a | 1.34M | 405K | 8.98M | 9.08M | 1.28M | 5.03M |
Financial Cash Flow | 4.81M | -53.69M | -511.44K | -10.49M | -44.39M | -49.34M | -23.05M | -2.72M | -8.27M | -15.05M | -5.58M | -2.33M | 1.14M | 1.64M | 688K | -23.87K | 1.34M | 405K | 205.72M | 9.08M | 1.28M | 5.03M |
Net Cash Flow | 138.82M | -39.21M | 7.02M | 20.19M | -13.43M | -17.01M | 46.29M | 3.74M | -31.05M | 15.58M | 2.48M | -35.31M | -7.29M | -5.17M | 8.12M | -65.58M | 19.09M | -99.36M | 174.31M | -63.97M | -35.03M | -115.76M |
Free Cash Flow | 85.09M | 32.52M | 44.5M | 44.38M | 44.14M | 1.28M | 30.06M | 16.94M | 15.72M | -18.61M | 14.25M | -13.17M | -3.05M | -32.18M | 10.32M | -15.4M | -27.91M | -46.83M | -25.96M | -40.41M | -38.21M | -54.72M |
Adj. Free Cash Flow | 83.11M | 33.39M | 44.5M | 38.47M | 38.7M | 4.69M | 21.11M | 8.62M | 7.13M | -24.35M | 2.49M | -24.98M | -15.32M | -41.65M | 3.41M | -23.72M | -37.97M | -53.85M | -34.53M | -47.5M | -45.96M | -62.54M |
Maintenance CapEx | -39K | -39K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 105K | n/a | n/a | n/a | n/a | n/a | n/a | -35K | n/a | n/a | -996.57K |
Growth CapEx | n/a | n/a | -69.76K | -65K | -98K | -17K | -56K | -85K | -128K | -12K | -59K | n/a | -227K | -509K | -134K | -37.68K | -39K | -79K | n/a | -159K | -228K | -184.43K |
Owner Earnings | 85.09M | 32.52M | 44.57M | 44.45M | 44.24M | 1.3M | 30.11M | 17.03M | 15.84M | -18.6M | 14.31M | -13.17M | -2.83M | -31.67M | 10.45M | -15.36M | -27.87M | -46.75M | -25.96M | -40.25M | -37.98M | -54.54M |
Add to Watchlist
Select watchlists to add or remove AUPH